Deferred Tax Assets, Valuation Allowance of Anebulo Pharmaceuticals, Inc. from 30 Jun 2020 to 30 Jun 2025

Taxonomy & unit: us-gaap: USD
Description: Amount of deferred tax assets for which it is more likely than not that a tax benefit will not be realized.
Summary: Anebulo Pharmaceuticals, Inc. quarterly Deferred Tax Assets, Valuation Allowance in USD history and change rate from 30 Jun 2020 to 30 Jun 2025.
Anebulo Pharmaceuticals, Inc. Deferred Tax Assets, Valuation Allowance for the quarter ending 30 Jun 2025 was $7,978,725, a 25% increase year-over-year.
Source SEC data: View on sec.gov

Deferred Tax Assets, Valuation Allowance, Quarterly (USD)

Deferred Tax Assets, Valuation Allowance, YoY Quarterly Change (%)

Anebulo Pharmaceuticals, Inc. Quarterly Deferred Tax Assets, Valuation Allowance (USD)

Period	Value	YoY Chg	Change %	Date	Report	Filed	Fiscal Year	Fiscal Period
Q2 2025	$7,978,725	+$1,570,407	+25%	30 Jun 2025	10-K	29 Sep 2025	2025	FY
Q2 2024	$6,408,318	+$1,722,401	+37%	30 Jun 2024	10-K	29 Sep 2025	2025	FY
Q2 2023	$4,685,917	+$2,456,425	+110%	30 Jun 2023	10-K	25 Sep 2024	2024	FY
Q2 2022	$2,229,492	+$1,431,540	+179%	30 Jun 2022	10-K	22 Sep 2023	2023	FY
Q2 2021	$797,952	+$763,025	+2185%	30 Jun 2021	10-K	09 Sep 2022	2022	FY
Q2 2020	$34,927			30 Jun 2020	10-K	22 Sep 2021	2021	FY

* An asterisk sign (*) next to the value indicates that the value is likely invalid.